These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7653891)

  • 1. Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells.
    Knapp DW; Chan TC; Kuczek T; Reagan WJ; Park B
    Am J Vet Res; 1995 Jun; 56(6):801-5. PubMed ID: 7653891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.
    Boria PA; Murry DJ; Bennett PF; Glickman NW; Snyder PW; Merkel BL; Schlittler DL; Mutsaers AJ; Thomas RM; Knapp DW
    J Am Vet Med Assoc; 2004 Feb; 224(3):388-94. PubMed ID: 14765798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
    Mohammed SI; Craig BA; Mutsaers AJ; Glickman NW; Snyder PW; deGortari AE; Schlittler DL; Coffman KT; Bonney PL; Knapp DW
    Mol Cancer Ther; 2003 Feb; 2(2):183-8. PubMed ID: 12589035
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Byer B; Schlein LJ; Rose B; Séguin B
    Can J Vet Res; 2020 Apr; 84(2):115-123. PubMed ID: 32255906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder.
    Knapp DW; Richardson RC; Chan TC; Bottoms GD; Widmer WR; DeNicola DB; Teclaw R; Bonney PL; Kuczek T
    J Vet Intern Med; 1994; 8(4):273-8. PubMed ID: 7983623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the effects of deracoxib and piroxicam on the in vitro viability of osteosarcoma cells from dogs.
    Royals SR; Farese JP; Milner RJ; Lee-Ambrose L; van Gilder J
    Am J Vet Res; 2005 Nov; 66(11):1961-7. PubMed ID: 16334957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
    de Vos J; Ramos Vega S; Noorman E; de Vos P
    Vet Comp Oncol; 2012 Sep; 10(3):206-13. PubMed ID: 22236048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines.
    Yoshitake R; Saeki K; Watanabe M; Nakaoka N; Ong SM; Hanafusa M; Choisunirachon N; Fujita N; Nishimura R; Nakagawa T
    Vet J; 2017 Mar; 221():38-47. PubMed ID: 28283079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes.
    Blanco FJ; Guitian R; Moreno J; de Toro FJ; Galdo F
    J Rheumatol; 1999 Jun; 26(6):1366-73. PubMed ID: 10381057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual coordinating behavior by three non-steroidal anti-inflammatory drugs from the oxicam family towards copper(II). Synthesis, X-ray structure for copper(II)-isoxicam, -meloxicam and -cinnoxicam-derivative complexes, and cytotoxic activity for a copper(II)-piroxicam complex.
    Cini R; Tamasi G; Defazio S; Hursthouse MB
    J Inorg Biochem; 2007 Aug; 101(8):1140-52. PubMed ID: 17592742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: comparison with nonsteroidal anti-inflammatory drugs.
    Curnock AP; Robson PA; Yea CM; Moss D; Gadher S; Thomson TA; Westwood R; Ruuth E; Williamson RA
    J Pharmacol Exp Ther; 1997 Jul; 282(1):339-47. PubMed ID: 9223572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
    Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
    J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention.
    Earnest DL; Hixson LJ; Alberts DS
    J Cell Biochem Suppl; 1992; 16I():156-66. PubMed ID: 1305681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
    Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
    J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs.
    Schmidt BR; Glickman NW; DeNicola DB; de Gortari AE; Knapp DW
    J Am Vet Med Assoc; 2001 Jun; 218(11):1783-6. PubMed ID: 11394830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer.
    Knapp DW; Glickman NW; Widmer WR; DeNicola DB; Adams LG; Kuczek T; Bonney PL; DeGortari AE; Han C; Glickman LT
    Cancer Chemother Pharmacol; 2000; 46(3):221-6. PubMed ID: 11021739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.
    Allstadt SD; Rodriguez CO; Boostrom B; Rebhun RB; Skorupski KA
    J Vet Intern Med; 2015 Jan; 29(1):261-7. PubMed ID: 25619518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study.
    Bernardi A; Frozza RL; Jäger E; Figueiró F; Bavaresco L; Salbego C; Pohlmann AR; Guterres SS; Battastini AM
    Eur J Pharmacol; 2008 May; 586(1-3):24-34. PubMed ID: 18371953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.